These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19666845)

  • 1. Synergistic effects of autologous cell and hepatocyte growth factor gene therapy for neovascularization in a murine model of hindlimb ischemia.
    Yamamoto Y; Matsuura T; Narazaki G; Sugitani M; Tanaka K; Maeda A; Shiota G; Sato K; Yoshida A; Hisatome I
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1329-36. PubMed ID: 19666845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
    Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic effect of vascular endothelial growth factor gene- or heme oxygenase-1 gene-modified endothelial progenitor cells on neovascularization of rat hindlimb ischemia model.
    Long J; Wang S; Zhang Y; Liu X; Zhang H; Wang S
    J Vasc Surg; 2013 Sep; 58(3):756-65.e2. PubMed ID: 23562340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
    Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound molecular imaging of angiogenesis induced by mutant forms of hypoxia-inducible factor-1α.
    Xie J; Liao Y; Yang L; Wu J; Liu C; Xuan W; Li M; Zhang L; Liu Y; Wu P; Bin J
    Cardiovasc Res; 2011 Nov; 92(2):256-66. PubMed ID: 21859818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor overexpression does not enhance adipose stromal cell-induced protection on muscle damage in critical limb ischemia.
    Olea FD; Locatelli P; Hnatiuk A; De Lorenzi A; Valdivieso L; Rocha E; Ramírez R; Laguens R; Crottogini A
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):184-8. PubMed ID: 25414254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model.
    Horikoshi-Ishihara H; Tobita M; Tajima S; Tanaka R; Oshita T; Tabata Y; Mizuno H
    J Vasc Surg; 2016 Dec; 64(6):1825-1834.e1. PubMed ID: 26597457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor.
    Kondoh K; Koyama H; Miyata T; Takato T; Hamada H; Shigematsu H
    Cardiovasc Res; 2004 Jan; 61(1):132-42. PubMed ID: 14732210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs.
    Onimaru M; Yonemitsu Y; Tanii M; Nakagawa K; Masaki I; Okano S; Ishibashi H; Shirasuna K; Hasegawa M; Sueishi K
    Circ Res; 2002 Nov; 91(10):923-30. PubMed ID: 12433837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes.
    Taniyama Y; Morishita R; Hiraoka K; Aoki M; Nakagami H; Yamasaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Circulation; 2001 Nov; 104(19):2344-50. PubMed ID: 11696476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
    Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
    J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.
    Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S
    J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
    Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of eIF3e promotes blood perfusion recovery after limb ischemia through stabilization of hypoxia-inducible factor 2α activity.
    Hashimoto T; Chen L; Kimura H; Endler A; Koyama H; Miyata T; Shibasaki F; Watanabe T
    J Vasc Surg; 2016 Jul; 64(1):219-226.e3. PubMed ID: 25758454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.
    Van Belle E; Witzenbichler B; Chen D; Silver M; Chang L; Schwall R; Isner JM
    Circulation; 1998 Feb; 97(4):381-90. PubMed ID: 9468212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells.
    Nakagami H; Maeda K; Morishita R; Iguchi S; Nishikawa T; Takami Y; Kikuchi Y; Saito Y; Tamai K; Ogihara T; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2542-7. PubMed ID: 16224047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2.
    Park C; Lee TJ; Bhang SH; Liu F; Nakamura R; Oladipupo SS; Pitha-Rowe I; Capoccia B; Choi HS; Kim TM; Urao N; Ushio-Fukai M; Lee DJ; Miyoshi H; Kim BS; Lim DS; Apte RS; Ornitz DM; Choi K
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):86-96. PubMed ID: 26586661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.